User:Mr. Ibrahem/Maralixibat

Maralixibat, sold under the brand name Livmarli, is a medication used to treat itchiness due to high bile salts in people with Alagille syndrome. It is used in people over the age of 2 month to 1 year. It is taken by mouth.

Commons side effects include diarrhea, abdominal pain, low fat soluble vitamins, liver problems, gastrointestinal bleeding, and bone fractures. It is believed to be safe in pregnancy. It is an ileal bile acid transporter (IBAT) inhibitor.

Maralixibat was approved for medical use in the United States in 2021. In Europe it is available as an orphan drug. In the United States 30 ml of 9.5 mg/mL solution costs about 54,000 USD as of 2022.